Rtw Investments, LP has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $6.23 Billion distributed in 69 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Rocket Pharmaceuticals, Inc. with a value of $477M, Immunocore Holdings PLC with a value of $391M, Axsome Therapeutics, Inc. with a value of $359M, Ultragenyx Pharmaceutical Inc. with a value of $331M, and Bruker Corp with a value of $314M.

Examining the 13F form we can see an increase of $139M in the current position value, from $6.09B to 6.23B.

Rtw Investments, LP is based out at New York, NY

Below you can find more details about Rtw Investments, LP portfolio as well as his latest detailed transactions.

Portfolio value $6.23 Billion
Healthcare: $6.23 Billion
Financial Services: $1.44 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 69
  • Current Value $6.23 Billion
  • Prior Value $6.09 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 16 stocks
  • Additional Purchases 25 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.